Frank Pallone actually said...

"I greatly appreciate his willingness to continue to address concerns he has heard about the legislative language."

"This review process has been critical to protecting and promoting public health by ensuring that the benefits of medical products that are prescribed to patients outweigh the risk."

"I am willing to have that discussion. However, broadening communication in the way it is proposed... would, in my opinion, undermine FDA's regulatory review process."

"I hope that our discussion today will help to inform whether or not it would be appropriate for this committee to take further action."